Checkpoint Inhibitor Induced Cardiotoxicity: Managing the Drawbacks of Our Newest Agents Against Cancer

Overview

Journal Oncotarget

Specialty Oncology

Date 2018 Jan 2

PMID 29290934

Citations 6

Authors

Karina Brustle

Bettina Heidecker

Affiliations

Soon will be listed here.

Citing Articles

Genetic Ablation of Mitigates Cardiac Damage during Experimental Autoimmune Myocarditis in Mice.

Rinkunaite I, Simoliunas E, Alksne M, Bartkute G, Labeit S, Bukelskiene V Biomolecules. 2022; 12(12).

PMID: 36551326 PMC: 9775225. DOI: 10.3390/biom12121898.

Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics.

Adhikari A, Asdaq S, Al Hawaj M, Chakraborty M, Thapa G, Bhuyan N Pharmaceuticals (Basel). 2021; 14(10).

PMID: 34681194 PMC: 8539940. DOI: 10.3390/ph14100970.

Strategies to Prevent Cardiotoxicity.

Graffagnino J, Kondapalli L, Arora G, Hawi R, Lenneman C Curr Treat Options Oncol. 2020; 21(4):32.

PMID: 32270293 DOI: 10.1007/s11864-020-0722-6.

Autoimmunity in Acute Myocarditis: How Immunopathogenesis Steers New Directions for Diagnosis and Treatment.

Bruestle K, Hackner K, Kreye G, Heidecker B Curr Cardiol Rep. 2020; 22(5):28.

PMID: 32198622 PMC: 7083821. DOI: 10.1007/s11886-020-01278-1.

Immune checkpoint inhibitor-mediated myocarditis and ventricular tachycardia storm.

McDowall L, Fernando S, Ange N, Yun J, Chia K HeartRhythm Case Rep. 2019; 5(10):497-500.

PMID: 31700793 PMC: 6831755. DOI: 10.1016/j.hrcr.2019.06.006.

References

Tarrio M, Grabie N, Bu D, Sharpe A, Lichtman A . PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis. J Immunol. 2012; 188(10):4876-84. PMC: 3345066. DOI: 10.4049/jimmunol.1200389. View

Joffre O, Santolaria T, Calise D, Al Saati T, Hudrisier D, Romagnoli P . Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med. 2007; 14(1):88-92. PMC: 2443705. DOI: 10.1038/nm1688. View

Wang D, Okoye G, Neilan T, Johnson D, Moslehi J . Cardiovascular Toxicities Associated with Cancer Immunotherapies. Curr Cardiol Rep. 2017; 19(3):21. PMC: 10176498. DOI: 10.1007/s11886-017-0835-0. View

Tay R, Blackley E, McLean C, Moore M, Bergin P, Gill S . Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy. Br J Cancer. 2017; 117(7):921-924. PMC: 5625667. DOI: 10.1038/bjc.2017.253. View

Heinzerling L, Ott P, Hodi F, Husain A, Tajmir-Riahi A, Tawbi H . Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy. J Immunother Cancer. 2016; 4:50. PMC: 4986340. DOI: 10.1186/s40425-016-0152-y. View